Teva Pharmaceutical Industries Ltd. announced the launch of the Authorized Generic of Detrol(R) LA (tolterodine tartrate extended-release capsules) 2 mg and 4 mg in the U.S. market.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.4 USD | -2.50% |
|
+0.92% | +57.09% |
07-01 | Sector Update: Health Care Stocks Retreat Late Afternoon | MT |
07-01 | Sector Update: Health Care Stocks Slipping in Afternoon Trading | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.09% | 18.57B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Announces Launch of Authorized Generic of Detrol(R)